BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
59.10
-1.08 (-1.79%)
At close: Apr 29, 2026
SHA:688166 Market Cap
SHA:688166 has a market cap or net worth of 24.97 billion as of April 29, 2026. Its market cap has increased by 49.13% in one year.
Market Cap
24.97B
Enterprise Value
26.73B
Revenue
1.22B
Ranking
n/a
PE Ratio
458.08
Stock Price
59.10
Market Cap Chart
Since November 8, 2019, SHA:688166's market cap has increased from 12.55B to 24.97B, an increase of 98.98%. That is a compound annual growth rate of 11.21%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hualan Biological Engineering | 26.43B |
| Suzhou Zelgen Biopharmaceuticals | 26.47B |
| Beijing Tiantan Biological Products | 28.63B |
| Xiamen Amoytop Biotech | 23.67B |
| Yili Chuanning Biotechnology | 21.94B |
| Sinocelltech Group | 19.51B |
| Chongqing Zhifei Biological Products | 35.74B |
| Shanghai RAAS Blood Products | 35.87B |